Blood cancer diagnostics can be defined as the wide range of screening & diagnosis tests associated with blood cancers such as lymphoma, leukemia, and myeloma. Bone marrow examination, blood sample tests, complete blood count tests, flow cytometry, cupping therapy, and genetic testing are prominent procedures in the diagnosis of blood cancer. An increase in the prevalence of oncological diseases and technological advancements in diagnostics are positively impacting the global blood cancer diagnostics market. Focus on detecting cancer at an early stage through molecular and RNA/DNA testing can widely improve the diagnosis.

The Market Research Survey on Blood Cancer Diagnostics CTC Tests by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand and growth. Sales Outlook of Blood Cancer Diagnostics CTC Tests as per the Market Research Survey is fairly positive and expected to register higher market growth during forecast period 2021 -2031. The market survey report also provides latest industry analysis on Blood Cancer Diagnostics CTC Tests with key analysis of Blood Cancer Diagnostics CTC Tests market drivers, trends, and influencing factors.

To Remain ‘Ahead’ Of Your Competitors, Request for Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=47

Key takeaways from Fact.MR’s research report include,

By test type, the CBC segment, which is currently valued at nearly US$ 77 million, is projected to grow at nearly 5% CAGR. In the North America blood cancer diagnostics market, these tests will continue to account for a significant share of overall revenues.
Owing to highly accurate diagnosis, blood testing will also continue to be a widely used test globally. Fact.MR projects this segment to rake in significant revenues by 2022.
On back of recent reports about the accuracy and benefits of using liquid biopsy, this segment is gaining traction globally. Research carried out at Massachusetts General Hospital Cancer Center and Harvard Medical School has shown that liquid biopsy can help patients with advanced cholangiocarcinoma. Fact.MR projects this segment to grow at a high CAGR through 2022.
The bone marrow test type is also being widely used by end-users owing to its efficacy in diagnosis and management. According to Fact.MR’s analysis, the bone marrow test type is anticipated to rake in significant revenues during the forecast period. Revenues from this segment are anticipated to grow at a healthy CAGR through 2022.
Hospital associated labs account for a significant revenue share of the overall demand for blood cancer diagnostics. According to Fact.MR’s analysis, this end-use segment is projected to grow at over 6% CAGR through 2022.

The Report Covers Exhaustive Analysis On:

Blood Cancer Diagnostics CTC Tests Market Drivers, Segments and Restraints.
Blood Cancer Diagnostics CTC Tests Market Survey and Dynamics
Blood Cancer Diagnostics CTC Tests Market Size & Demand
Blood Cancer Diagnostics CTC Tests Key Trends/Issues/Challenges
Blood Cancer Diagnostics CTC Tests Sales, Competition & Companies involved

Get Customization on this Research Report for specific research solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=47

Competition Tracking

The key companies profiled in Fact.MR’s research include

Abbott Laboratories
Roche Holding A.G.
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc
NeoGenomics Laboratories Inc.

* Full List of Key Players Available on Demand*

Key questions answered in Blood Cancer Diagnostics CTC Tests Market Survey Report:

What is the current scenario and key trends in Blood Cancer Diagnostics CTC Tests Market?
What are the key strategies companies are adopting to increase their consumer base?
What are the key categories within the Blood Cancer Diagnostics CTC Tests segments and their future potential?
What are the major Blood Cancer Diagnostics CTC Tests Market drivers and their expected impact during the short, medium, and long terms?
What is the Blood Cancer Diagnostics CTC Tests Market size and what are the opportunities for the key players?

Buy Now for Exclusive Analyst Support – https://www.factmr.com/checkout/47

Essential Takeaways from the Market Report

Comparison of prominent players operating in the Blood Cancer Diagnostics CTC Tests market.
Identification of Blood Cancer Diagnostics CTC Tests Market drivers, restraints and other forces impacting the global market.
Recent developments and key strategies adopted by market players.
Study of the micro and macro-economic growth indicators.
Impact of the various factors on the value chain.
Evaluation of current Blood Cancer Diagnostics CTC Tests market size, forecast and technological advancements within the industry.

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/with-covid-vaccines-development-underway-and-other-prominent-developments-antibodies-market-is-expected-to-witness-fruitful-growth-observes-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain

Biomedical Textiles Market – According to Fact.MR, the global biomedical textiles market was valued at around US$ 12 Bn in 2020, and is projected to expand 1.4X to top US$ 17 Bn by 2031. Technological advancements in textiles for better treatment and increasing health awareness among people are key factors expected to drive market growth at a CAGR above 5% across the 2021-2031 forecast period.

Solid State Battery Market – Newly-released solid state battery industry analysis by Fact.MR shows that global sales of solid state batteries in 2020 were valued at US$ 56.9 Mn. At around 30% CAGR, projected market growth during 2021 – 2031 is expected to be significantly higher than previous years. By 2031, the market for portable solid state batteries is expected to account for an absolute dollar opportunity of nearly US$ 911 Mn. 

Periodontal Dental Services Market – According to Fact.MR’s periodontal dental services industry analysis, revenue in the global market topped US$ 14 Bn in 2020, in spite of recessionary impacts induced by the COVID-19 pandemic. Demand remained high amid rising occurrences of periodontal diseases worldwide. The market is expected to reach a valuation of around US$ 27.4 Bn by 2031, expanding at an impressive CAGR of 10% over the forecast period of 2021-2031.

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: [email protected]
Website: https://www.factmr.com

The post Blood Cancer Diagnostics CTC Tests projected to grow at 6.4% CAGR through 2022 appeared first on TOP NEWS PRESS.